| 1 minute

TC BioPharm Work with University College London on Cancer Project

TC BioPharm have joined forces with University College London to develop treatment for Leukaemia.

The agreement aims to progress UCL’s gene-modified T cell therapies that are capable of treating cancers of the blood.

To read the full article, click here.

Back to News

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News